Topic: Ba2 Variant

Former FDA Administrator and Pfizer board member Scott Gottlieb appeared on CNBC to discuss the BA.2 variant surge in the Northeast. Critics argue that Gottlieb's frequent media appearances are driven by Pfizer's significant advertising spend on news networks. The discussion suggests that case numbers are being manipulated and that the "XE" variant is a marketing rebrand of previous Omicron strains.